Advertisement

Topics

Companies Related to "PRAECIS PHARMACEUTICALS INCORPORATED" [Most Relevant Company Matches] [Advanced Search Results] RSS

00:42 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "PRAECIS PHARMACEUTICALS INCORPORATED" found in our extensive corporate database of over 50,000 company records.

Showing "PRAECIS PHARMACEUTICALS INCORPORATED" Companies 1–25 of 1,900+

Extremely Relevant

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for cancer indications, including non-Hodgkin's lymphoma and solid tumors, as well as an innovative drug discovery technology, Direct Sele...


Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceuticals) technology. LEAP combines the power of biological selection with the advantages of medicinal chemistry in a unique molecular evolution process. PRAECIS employed LEAP in the development of PLENA...

Probably Relevant

X-BODY BioSciences

X-BODY BioSciences was founded in 2008 by Richard Wagner, Ph.D., Gordon Binder, and Brant Binder, MBA. Dr. Wagner previously co-developed the fibronectin domain antibody-mimetic platform at Phylos, later acquired by Bristol Myers Squibb, and the DirectSelect small molecule library screening system at Praecis Pharmaceuticals, acquired by GlaxoSmithKline in 2007. Mr. Gordon Binder is the former C...


Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as well as developing technologies to solubilise insoluble pharmaceuticals.

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration of skin scarring and other fibrotic disorders. EXC 001 was co-discovered by Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Excaliard, and licensed to Excaliard Pharmaceuticals.

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-being of millions of people. Serenity Pharmaceuticals is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective ...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil.

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

Primex Pharmaceuticals AG

Primex Pharmaceuticals aims to become the leading global innovative anaesthesia company, and to expand in paediatric pharmaceuticals.

Future Pharmaceuticals

Future Pharmaceuticals magazine draws connections between industry leaders and pharmaceutical companies. Future Pharmaceuticals recommends next generation and groundbreaking strategies to ensure success across the enterprise.

KalGene Pharmaceuticals Inc.

KalGene Pharmaceuticals Inc. is a biotech company, currently residing at JLABS @ Toronto, Ontario. The mission of KalGene Pharmaceuticals is to develop precision medicine therapeutics for effective treatment of Alzheimer’s disease.

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary incontinence. Our current portfolio of products are listed below. Please choose the product you are interested in learning more about:

Mountain View Pharmaceuticals Incorporated

Mountain View Pharmaceuticals is dedicated to the development and application of inovative chemical technology for enhancing the utility of protein-based pharmaceuticals.

Gemini Pharmaceuticals Inc.

Gemini Pharmaceuticals Inc. is a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 18 billion tablets / capsules per year. The quality of the o...

QView Medical, Inc.

QView Medical, incorporated in 2006, developed its deep learning AI-CAD for automated breast ultrasound systems (ABUS). The QVCAD system is FDA approved and can now be used with any currently installed GE Invenia system. For more information, visit www.qviewmedical.com

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified ...

LCG Systems

Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) was incorporated in 2002 as a SBA Small Disadvantaged Business (SDB) to focus on the growing demand for quality health information technology services to the Federal Governme...

Cubist Pharmaceuticals

Cubist Pharmaceuticals Incorporated is a drug company focused on the discovery, development and commercialization of novel drugs to treat infections. Daptomycin, the Company's in-licensed lead product, is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections. Cubist Pharmaceuticals began Phase III cli...

Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, and is the 4th largest pharmaceutical company in the U.S. based on prescriptions filled. Together, all Lupin-owned entities combine to make up the 7th largest pharmaceutical company in the world in total sales. Lupin Pharmaceuticals, Inc. is dedicated to delivering h...

Elevation Pharmaceuticals, Inc.

Elevation Pharmaceuticals is a biopharmaceutical company focused on developing new inhaled therapies for patients with respiratory disease. The Company was founded in 2008 by Cam Garner, formerly Chairman and CEO of Dura Pharmaceuticals, Bill Gerhart, formerly President and CEO of Mpex Pharmaceuticals, and Ahmet Tutuncu, formerly VP of Medical Affairs at Verus Pharmaceuticals. The Company's init...

Lund University Centre for Research on Pharmaceuticals

The purpose of the Center for Research on Pharmaceuticals is to establish an internationally known, multidisciplinary network for research and development of pharmaceuticals and medical device, from which the industry can buy services and within which inventions at the university will obtain a good environment for future commersialization.

Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.

Savient Pharmaceuticals, Inc.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing KRYSTEXXA(TM) (pegloticase) for the treatment of chronic gout in patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase®, from Duke University and Mountain View Pharmaceuticals, Inc. Savient al...

Pilot Pharmaceuticals

Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...

Aries Pharmaceuticals, Inc.

Aries Pharmaceuticals, Inc. (Aries) is a specialty pharmaceutical company commercializing best-in-class gastroenterology products for the United States market with a focus on products utilized in endoscopy and for the treatment of specific gastrointestinal diseases. The company’s initial portfolio of four products, three of which are still in devel...


More From BioPortfolio on "PRAECIS PHARMACEUTICALS INCORPORATED"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks